A detailed history of Washington Trust CO transactions in Novo Nordisk A S stock. As of the latest transaction made, Washington Trust CO holds 905 shares of NVO stock, worth $97,749. This represents 0.0% of its overall portfolio holdings.

Number of Shares
905
Previous 1,155 21.65%
Holding current value
$97,749
Previous $164,000 34.76%
% of portfolio
0.0%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$119.07 - $145.42 $29,767 - $36,355
-250 Reduced 21.65%
905 $107,000
Q2 2024

Jul 15, 2024

SELL
$122.71 - $146.91 $42,948 - $51,418
-350 Reduced 23.26%
1,155 $164,000
Q1 2024

Apr 23, 2024

SELL
$102.11 - $135.92 $3,573 - $4,757
-35 Reduced 2.27%
1,505 $193,000
Q4 2023

Jan 18, 2024

BUY
$87.78 - $105.45 $18,170 - $21,828
207 Added 15.53%
1,540 $159,000
Q3 2023

Oct 18, 2023

BUY
$90.94 - $199.54 $62,384 - $136,884
686 Added 106.03%
1,333 $121,000
Q2 2023

Jul 27, 2023

BUY
$155.98 - $172.65 $54,125 - $59,909
347 Added 115.67%
647 $104,000
Q1 2023

May 10, 2023

BUY
$132.34 - $159.14 $52,936 - $63,655
400 New
400 $63,000
Q1 2023

May 04, 2023

SELL
$132.34 - $159.14 $39,702 - $47,741
-300 Closed
0 $64,000
Q4 2022

Jul 27, 2023

SELL
$102.55 - $135.33 $10,255 - $13,533
-100 Reduced 25.0%
300 $40,000
Q4 2022

Feb 08, 2023

BUY
$102.55 - $135.33 $5,127 - $6,766
50 Added 20.0%
300 $41,000
Q2 2021

Aug 05, 2021

SELL
$67.66 - $84.76 $270 - $339
-4 Reduced 1.57%
250 $21,000
Q3 2020

Nov 05, 2020

SELL
$63.69 - $70.22 $1,210 - $1,334
-19 Reduced 6.96%
254 $17,000
Q2 2020

Aug 04, 2020

SELL
$58.54 - $67.94 $9,659 - $11,210
-165 Reduced 37.67%
273 $18,000
Q1 2020

May 07, 2020

BUY
$49.46 - $64.78 $21,663 - $28,373
438 New
438 $27,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $244B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Washington Trust CO Portfolio

Follow Washington Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Washington Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Washington Trust CO with notifications on news.